| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
44,696,000 |
| Market
Cap: |
11.62(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.156 - $0.62 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tenax Therapeutics is focused on identifying, developing and commercializing late-stage pharmaceutical therapeutic products for serious cardiovascular and pulmonary diseases. Co. owns a license granting Life Newco, Inc., its wholly owned subsidiary, a sublicensable right to develop and commercialize pharmaceutical products containing levosimendan. Co.'s programs include: TNX-103 and TNX-102 (levosimendan), a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and TNX-201(imatinib), a tyrosine kinase inhibitor, which changed the treatment of chronic myeloid leukemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
Director |
– • • |
2020-09-02 |
4 |
B |
$1.47 |
$29,400 |
D/D |
20,000 |
1,951,995 |
3.92 |
25% |
|
| Boyd Steven |
Director |
– • • |
2020-09-01 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,931,995 |
2.17 |
24% |
|
| Boyd Steven |
Director |
– • • |
2020-09-01 |
4 |
B |
$1.46 |
$43,800 |
D/D |
30,000 |
1,931,995 |
3.92 |
24% |
|
| Boyd Steven |
Director |
– • • |
2020-08-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,901,995 |
2.17 |
27% |
|
| Boyd Steven |
Director |
– • • |
2020-08-31 |
4 |
B |
$1.45 |
$29,000 |
D/D |
20,000 |
1,901,995 |
3.92 |
27% |
|
| Boyd Steven |
Director |
– • • |
2020-08-27 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,881,995 |
2.17 |
17% |
|
| Boyd Steven |
Director |
– • • |
2020-08-27 |
4 |
B |
$1.50 |
$18,000 |
D/D |
12,000 |
1,881,995 |
3.92 |
17% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-26 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,869,995 |
1.42 |
17% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-26 |
4 |
B |
$1.50 |
$18,000 |
D/D |
12,000 |
1,869,995 |
2.37 |
17% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,857,995 |
1.42 |
10% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-25 |
4 |
B |
$1.53 |
$26,333 |
D/D |
17,211 |
1,857,995 |
2.37 |
10% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-24 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,840,784 |
1.42 |
24% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-08-24 |
4 |
B |
$1.47 |
$8,367 |
D/D |
5,692 |
1,840,784 |
2.37 |
24% |
|
| Boyd Steven |
Director |
– • • |
2020-08-21 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,835,092 |
2.17 |
22% |
|
| Boyd Steven |
Director |
– • • |
2020-08-21 |
4 |
B |
$1.44 |
$167,388 |
D/D |
116,242 |
1,835,092 |
3.92 |
22% |
|
| Boyd Steven |
Director |
– • • |
2020-08-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,718,850 |
2.17 |
20% |
|
| Boyd Steven |
Director |
– • • |
2020-08-20 |
4 |
B |
$1.53 |
$190,442 |
D/D |
124,472 |
1,718,850 |
3.92 |
20% |
|
| Boyd Steven |
Director |
– • • |
2020-08-19 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
1,594,378 |
2.17 |
27% |
|
| Boyd Steven |
Director |
– • • |
2020-08-19 |
4 |
B |
$1.45 |
$102,612 |
D/D |
70,767 |
1,594,378 |
3.92 |
27% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-07-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,523,611 |
|
18% |
|
| Boyd Steven |
10% Owner |
– – • |
2020-07-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,523,611 |
|
18% |
|
| Blanck Ronald R |
|
• • – |
2020-05-18 |
4 |
B |
$0.95 |
$4,774 |
D/D |
5,000 |
6,062 |
0.01 |
115% |
|
| Jebsen Michael B |
CFO |
• – – |
2018-07-31 |
4 |
|
$6.25 |
$35,750 |
D/D |
5,720 |
34,680 |
|
- |
|
| Jebsen Michael B |
CFO |
• – – |
2018-03-30 |
4 |
|
$5.42 |
$34,824 |
D/D |
6,425 |
12,310 |
|
- |
|
| Jebsen Michael B |
CFO |
• – – |
2017-12-29 |
4 |
|
$0.43 |
$42 |
D/D |
98 |
68,264 |
|
- |
|
172 Records found
|
|
Page 2 of 7 |
|
|
